{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:37:23Z","timestamp":1793972243700,"version":"4.8.0"},"reference-count":35,"publisher":"Informa UK Limited","issue":"4","funder":[{"DOI":"10.13039\/100012386","name":"Magee-Womens Research Institute CARES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K12DA050607"],"award-info":[{"award-number":["K12DA050607"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Addictive Diseases"],"published-print":{"date-parts":[[2025,10,2]]},"DOI":"10.1080\/10550887.2024.2391156","type":"journal-article","created":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T20:30:53Z","timestamp":1724272253000},"page":"394-401","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Implications of xylazine exposure in pregnancy: a narrative review"],"prefix":"10.1080","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0075-2651","authenticated-orcid":false,"given":"Ilana","family":"Hull","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh School of Medicine","place":["Pittsburgh, USA"]},{"name":"Division of General Internal Medicine, Department of Medicine, University of Pittsburgh","place":["Pittsburgh, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raagini","family":"Jawa","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, University of Pittsburgh","place":["Pittsburgh, USA"]},{"name":"Center for Research on Healthcare, University of Pittsburgh School of Medicine","place":["Pittsburgh, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Shang","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, University of Pittsburgh","place":["Pittsburgh, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh School of Medicine","place":["Pittsburgh, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cambria","family":"King","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh School of Medicine","place":["Pittsburgh, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"McMurtrie","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh School of Medicine","place":["Pittsburgh, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Krans","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh School of Medicine","place":["Pittsburgh, USA"]},{"name":"Magee-Womens Research Institute","place":["Pittsburgh, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000717"},{"key":"e_1_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7226a4"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000472"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108236"},{"key":"e_1_3_1_6_1","unstructured":"Substance Abuse and Mental Health Services Administration. Evidence-based whole-person care for pregnant people who have opioid use disorder. Advisory Publication No. PEP23-02-01-002. Rockville MD: Substance Abuse and Mental Health Services Administration. 2024."},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.17045"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addicn.2024.100155"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00879-7"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2303120"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109380"},{"key":"e_1_3_1_12_1","unstructured":"Drug Enforcement Agency. DEA joint intelligence report: the growing threat of xylazine and its mixture with illicit drugs. 2022. [accessed 2024 February 11]. https:\/\/www.dea.gov\/sites\/default\/files\/2022-12\/The%20Growing%20Threat%20of%20Xylazine%20and%20its%20Mixture%20with%20Illicit%20Drugs.pdf"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7037a5"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.7326\/M23-2001"},{"key":"e_1_3_1_15_1","unstructured":"The White House. Biden-Harris administration designates fentanyl combined with xylazine as an emerging threat to the United States. ONDCP. 2023 April 12. [accessed 2024 May 17]. https:\/\/www.whitehouse.gov\/ondcp\/briefing-room\/2023\/04\/12\/biden-harris-administration-designates-fentanyl-combined-with-xylazine-as-an-emerging-threat-to-the-united-states\/."},{"key":"e_1_3_1_16_1","unstructured":"The White House. In continued fight against overdose epidemic the white house releases national response plan to address the emerging threat of fentanyl combined with xylazine. ONDCP. 2023. [accessed 2024 May 17]. https:\/\/www.whitehouse.gov\/ondcp\/briefing-room\/2023\/07\/11\/in-continued-fight-against-overdose-epidemic-the-white-house-releases-national-response-plan-to-address-the-emerging-threat-of-fentanyl-combined-with-xylazine\/."},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41073-019-0064-8"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1127020"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(84)90712-9"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.58.211"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.2002.63.1695"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.17161\/kjm.vol16.20624"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.theriogenology.2017.12.033"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2010.159"},{"key":"e_1_3_1_25_1","unstructured":"Shuda S Lam H. Characterization of xylazine test strips for use in drug checking. 2022. https:\/\/www.cfsre.org\/nps-discovery\/drug-checking CFSRE"},{"key":"e_1_3_1_26_1","unstructured":"Krotulski A Shinefield J Debord J Teixeira Da Silva D Logan B. Evaluation of xylazine test strips (BTNX) for drug checking purposes. 2023. [accessed 2023 May 20]. https:\/\/www.cfsre.org\/nps-discovery\/drug-checking\/evaluation-of-xylazine-test-strips-btnx-for-drug-checking-purposes"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000955"},{"key":"e_1_3_1_28_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36864"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1556745"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002235"},{"key":"e_1_3_1_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15582"},{"key":"e_1_3_1_32_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28160"},{"key":"e_1_3_1_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/29767342231214472"},{"key":"e_1_3_1_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.0572"},{"key":"e_1_3_1_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2022.2159427"},{"key":"e_1_3_1_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-023-06390-y"}],"container-title":["Journal of Addictive Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10550887.2024.2391156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T11:57:33Z","timestamp":1759838253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10550887.2024.2391156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10,2]]}},"alternative-id":["10.1080\/10550887.2024.2391156"],"URL":"https:\/\/doi.org\/10.1080\/10550887.2024.2391156","relation":{},"ISSN":["1055-0887","1545-0848"],"issn-type":[{"value":"1055-0887","type":"print"},{"value":"1545-0848","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=wjad20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=wjad20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-08-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}